Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24–April 21, 2020

On May 1, 2020, this report was posted online as an MMWR Early Release.

Anne Schuchat, MD; CDC COVID-19 Response Team (

Summary

What is already known about this topic?

The first confirmed coronavirus disease 2019 (COVID-19) case in the United States was reported on January 21, 2020. The outbreak appeared contained through February, and then accelerated rapidly.

What is added by this report?

Various factors contributed to accelerated spread during February–March 2020, including continued travel-associated importations, large gatherings, introductions into high-risk workplaces and densely populated areas, and cryptic transmission resulting from limited testing and asymptomatic and presymptomatic spread. Targeted and communitywide mitigation efforts were needed to slow transmission.

What are the implications for public health practice?

Factors that amplified the March acceleration and associated mitigation strategies that were implemented can inform public health decisions as the United States prepares for potential re-emergences.

Figures

Related Materials

• PDF [164K]

From January 21 through February 23, 2020, a total of 14 cases of coronavirus disease 2019 (COVID-19) were diagnosed in six U.S. states, including 12 cases in travelers arriving from China and two in household contacts of persons with confirmed infections. An additional 39 cases were identified in persons repatriated from affected areas outside the United States (1). Starting in late February, reports of cases with no recent travel to affected areas or links to known cases signaled the initiation of pandemic spread in the United States (2). By mid-March, transmission of SARS-CoV-2, the virus that causes COVID-19, had accelerated, with rapidly increasing case counts indicating established transmission in the United States. Ongoing traveler importation of SARS-CoV-2, attendance at professional and social events, introduction into facilities or settings prone to amplification, and challenges in virus detection all contributed to rapid acceleration of transmission during March. Public health responses included intensive efforts to detect cases and trace contacts, and implementation of multiple community mitigation strategies. Because most of the population remains susceptible to infection, recognition of factors associated with amplified spread during the early acceleration period will help inform future decisions as locations in the United States scale back some components of mitigation and strengthen systems to detect a potential transmission resurgence. U.S. circulation of SARS-CoV-2 continues, and sustained efforts will be needed to prevent future spread within the United States.

The first cases of COVID-19 in the United States occurred in January and February 2020 in travelers from China’s Hubei Province, where the virus was first recognized, and their household contacts (1). Beginning in late February, cases with no history of international travel and no contact with infected persons were recognized (1). By mid-March, transmission had become widespread, and by April 21, a total of 793,669 confirmed COVID-19 cases had been reported in the United States, the majority resulting from widespread community transmission (

Travel and COVID-19 Spread

Continued introductions of SARS-CoV-2 from outside the United States contributed to the initiation and acceleration of domestic COVID-19 cases in March. After Chinese authorities halted travel from Wuhan and other cities in Hubei Province on January 23, followed by U.S. restrictions on non-U.S. travelers from China issued on January 31 (effective February 2), air passenger journeys from China decreased 86%, from 505,560 in January to 70,072 in February. However, during February, 139,305 travelers arrived from Italy and 1.74 million from all Schengen countries,* where the outbreak was spreading widely and rapidly. Travelers from Italy and all Schengen countries decreased 74% to 35,877 and 50% to 862,432, respectively, in March.† Genomic analysis of outbreak strains suggested an introduction from China to the state of Washington around February 1.§ However, examination of strains collected from northern California during early February to mid-March indicated multiple introductions resulting from international travel (from China and Europe) as well as from interstate travel.¶ Sequencing of strains collected in the New York metropolitan area in March also suggested origins in Europe and other U.S. regions.** Returning cruise ship travelers also contributed to amplification during this time (3). Persons from many countries are in close contact on cruises, and crew members continue to work on ships for multiple voyages. As a result, passengers returning from cruises contributed to the early acceleration phase. For example, 101 persons who had been on nine separate Nile River cruises during February 11–March 5 returned to 18 states and had a positive test result for SARS-CoV-2, nearly doubling the total number of known COVID-19 cases in the United States at that time (

Public health steps to mitigate continued importations of the virus included travel restrictions for non-U.S. citizens or permanent residents arriving from China beginning in early February and later expanded to include other countries with widespread sustained transmission (

Events and Gatherings

Various gatherings of persons from different locations, followed by return to their home communities, played a notable role in the early U.S. spread of COVID-19. During February 2020, the number of confirmed cases originating in the United States was low and appeared contained; thus, federal and local jurisdictions did not recommend restrictions on gatherings. However, during the last week of February, several large events led to further spread of the disease. These included Mardi Gras celebrations in Louisiana with more than 1 million attendees, an international professional conference held in Boston, Massachusetts, with approximately 175 attendees, and a funeral in Albany, Georgia, with more than 100 attendees (Figure 1). In the weeks after these events, amplifications in the host locations contributed to increasing U.S. case counts (5). Dougherty County, Georgia, a small rural county that includes Albany, had one of the highest cumulative incidences of COVID-19 (1,630/100,000 population) in the country. The substantial transmissibility of the virus and severity of COVID-19 triggered a series of recommendations, beginning in mid-March, to limit mass gatherings and travel (Table).

Workplaces and Settings Contributing to Accelerated Spread

Skilled nursing and long-term care facilities (6) and hospitals (7) are settings in which persons at higher risk for severe COVID-19 illness are in close contact with staff members, many of whom work at multiple facilities. Other workplaces also facilitated amplification of virus transmission, including critical infrastructure sectors, such as multiple meat packing facilities in rural areas. Clusters of cases related to religious service attendance have been reported within the United States and worldwide (8). Congregate, high-density settings also might contribute to the spread of COVID-19 (9). For example, population density might account for the very high numbers of COVID-19 cases in the New York metropolitan area (

Cryptic Transmission

Unrecognized transmission played a key role in the initiation and acceleration phases of the U.S. outbreak. Cases were not detected during this time for various reasons. First, introduction of the virus into the United States occurred during the annual influenza season. Although syndromic surveillance systems tracked respiratory illness in outpatient settings and emergency departments in many U.S. jurisdictions, including areas where early COVID-19 clusters were detected, such as Seattle, Washington, none of these systems detected unusual trends during the early part of the acceleration period because of the preponderance of seasonal influenza illness. After the first community case in Santa Clara, California, was confirmed on February 27, the county conducted COVID-19 surveillance with polymerase chain reaction–based virus testing during March 5–14 at four urgent care centers. Influenza accounted for 23% of respiratory illnesses; among those who had a negative test result for influenza, 11% had a positive test result for SARS-CoV-2, representing approximately 8% of patients with respiratory symptoms (10). Seroprevalence data from Seattle during March 2020, a period when transmission of the virus was rapidly accelerating, suggested that there were limited undetected infections in healthy adults without respiratory illness (1 of 221 remnant clinical sera representing a convenience sample tested seropositive [Helen Chu, University of Washington School of Public Health, personal communication, April 2020]); at the population level, this still translates into substantial numbers of unrecognized community infections. No samples from 59 children with acute respiratory infections during January–March were seropositive (Janet Englund, Seattle Children’s Hospital and University of Washington, personal communication, April 2020). Because the incidence of SARS-CoV-2 infections was still relatively low during the initiation and early acceleration periods, as evidenced by seroprevalence data, widespread testing would have been needed to detect all cases. The contribution of spread from persons without symptoms also complicated detection and containment (11). Public health actions included expanded surveillance and testing capacity and community measures, such as enhanced teleworking and stay-at-home orders, school closures, social distancing, and use of cloth face coverings (Table).

Discussion

The acceleration phase of a pandemic is complex and requires a multifaceted and rapidly adapting public health response. During a 3-week period in late February to early March, the number of U.S. COVID-19 cases increased more than 1,000-fold. Various community mitigation interventions were implemented with the aim of reducing further spread and controlling the impact on health care capacity. Recognition of factors associated with amplified spread during this early acceleration period will help inform future decisions as locations in the United States scale back some components of mitigation and strengthen systems to detect transmission resurgence.

The findings in this report are subject to at least five limitations. First, the various factors facilitating viral spread described in this report occurred simultaneously; therefore, it is not possible to quantify the relative contribution of each to the outbreak trajectory in the United States. Second, the examples of factors contributing to amplification are illustrative and not meant to be comprehensive. Third, because the mitigation strategies highlighted here were implemented concurrently, the ability to estimate the relative impact of each intervention is limited. Fourth, the epidemic curve presented was likely affected by limited testing, particularly in the early phases of the outbreak. Finally, the case counts presented are an underestimate of the actual number of COVID-19 cases in the United States.

As the pandemic evolves, control efforts must be continuously refined. Certain interventions that were critical in the early stages, such as quarantine and airport screening, might have less impact when transmission is widespread in the community. However, many elements of the mitigation strategies used during the acceleration phase will still be needed in later stages of the outbreak. Preliminary results from serologic surveys suggest that even in the U.S. regions with the largest numbers of recognized cases, most persons have not been infected and remain susceptible.§§,¶¶ Therefore, sustained and concerted efforts will be needed to prevent future spread of SARS-CoV-2 within the United States.

Corresponding author: Anne Schuchat, CDC COVID-19 Response Team, aschuchat@cdc.gov, 404-639-7000.

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

• Includes Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, and Switzerland. Travel within the Schengen Area is permitted without border controls.

† Air travel data provided by U.S. Customs and Border Protection’s Office of Planning, Program Analysis, and Evaluation (PPAE).

§ https://www.medrxiv.org/content/10.1101/2020.04.02.20051417v2.

¶ https://www.medrxiv.org/content/10.1101/2020.03.27.20044925v1.

** https://www.medrxiv.org/content/10.1101/2020.04.08.20056929v2.

†† https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover.html.

§§ https://www.governor.ny.gov/news/video-audio-photos-rush-transcript-amid-ongoing-covid-19-pandemic-governor-cuomo-announces-12.

¶¶ https://www.medrxiv.org/content/10.1101/2020.04.14.20062463v1.

References

• Jernigan DB; CDC COVID-19 Response Team. Update: public health response to the coronavirus disease 2019 outbreak—United States, February 24, 2020. MMWR Morb Mortal Wkly Rep 2020;69:216–9. CrossRef PubMed
• Qualls N, Levitt A, Kanade N, et al.; CDC Community Mitigation Guidelines Work Group. Community mitigation guidelines to prevent pandemic influenza—United States, 2017. MMWR Recomm Rep 2017;66(No. RR-1). CrossRef PubMed
• Moriarty LF, Plucinski MM, Marston BJ, et al.; CDC Cruise Ship Response Team; California Department of Public Health COVID-19 Team; Solano County COVID-19 Team. Public health responses to COVID-19 outbreaks on cruise ships—worldwide, February–March 2020. MMWR Morb Mortal Wkly Rep 2020;69:347–52. CrossRef PubMed
• Patel A, Jernigan DB; 2019-nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019–February 4, 2020. MMWR Morb Mortal Wkly Rep 2020;69:140–6. CrossRef PubMed
• Bialek S, Bowen V, Chow N, et al.; CDC COVID-19 Response Team. COVID-19 Response Team. Geographic differences in covid-19 cases, deaths, and incidence—United States, February 12–April 7, 2020. MMWR Morb Mortal Wkly Rep 2020;69:465–71. CrossRef PubMed
• McMichael TM, Currie DW, Clark S, et al. Epidemiology of Covid-19 in a long-term care facility in King County, Washington. N Engl J Med 2020;NEJMoa2005412. CrossRef PubMed
• Heinzerling A, Stuckey MJ, Scheuer T, et al. Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient—Solano County, California, February 2020. MMWR Morb Mortal Wkly Rep 2020;69:472–6. CrossRef PubMed
• Pung R, Chiew CJ, Young BE, et al.; Singapore 2019 Novel Coronavirus Outbreak Research Team. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet 2020;395:1039–46. CrossRef PubMed
• Rocklöv J, Sjödin H. High population densities catalyze the spread of COVID-19. J Travel Med 2020; Epub March 29, 2020. CrossRef PubMed
• Zwald ML, Lin W, Sondermeyer Cooksey GL, et al. Rapid sentinel surveillance for COVID-19—Santa Clara County, California, March 2020. MMWR Morb Mortal Wkly Rep 2020;69:419–21. CrossRef PubMed
• Gandhi M, Yokoe DS, Havlir DV. Asymptomatic transmission, the Achilles’ Heel of current strategies to control Covid-19. 2020. N Engl J Med 2020; Epub April 24, 2020. CrossRef PubMed

###

**Abbreviation: **COVID-19 = coronavirus disease 2019.

• Cumulative case count was 13 before February 20, 2020.

###

**Abbreviations: **COVID-19 = coronavirus disease 2019; DC = District of Columbia; DE = Delaware; RI = Rhode Island.

###

Multiple interrelated factors that complicated identification and isolation of cases and tracing of contacts contributed to the COVID-19 outbreak in New York.

Population density

• New York City’s boroughs represent the top four population-dense U.S. counties.
• Reliance on mass transit (subways, buses, and ferries) results in frequent, prolonged close contact.
• High prevalence of apartment living contributed to household spread.

Domestic and global destination

• Three major airports serve as domestic and global hubs, serving >1 million air passengers per week.
• Approximately 1.6 million persons commute into Manhattan daily during the work week, primarily using mass transit.

Large number of crowded settings housing vulnerable populations

• Long-term care facilities, skilled nursing facilities: At least 80 facilities in the state have reported five or more cases as of April 21; initial infections were noted in early March.
• Correctional institutions: As of April 21, incidence in Department of Corrections and Community Supervision facilities was approximately seven times that in the state overall.
• Homeless shelters: As of the week of April 21, approximately 600 cases were confirmed among shelter residents and other persons experiencing homelessness.

Large gatherings

• Initial cases in Westchester County were associated with attendance at large gatherings in late February.
• All types of large work and social gatherings accelerated transmission across jurisdictional boundaries.

Where this page came from

This page was imported from Centers for Disease Control and Prevention. Material produced by the Centers for Disease Control and Prevention is a work of the United States government and is in the public domain.

Nobody has written it yet — it is the source material at a new address, which is why search engines are asked to skip it and why no one earns from it. It is up for grabs: take it on, and it is yours to rewrite and to earn from.